Tag Archives: U.S.

Roche's Tecentriq wins speedy U.S. review in small cell lung cancer

The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann ZURICH (Reuters) – Roche’s Tecentriq immunotherapy with chemotherapy won priority review in the United States for the initial treatment of extensive-stage small cell lung cancer (SCLC), the company said, setting up possible approval by March 18.… Read More »